Design and virtual screening of novel fluoroquinolone analogs as effective mutant DNA GyrA inhibitors against urinary tract infection-causing fluoroquinolone resistant Escherichia coli
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Design and virtual screening of novel fluoroquinolone analogs as effective mutant DNA GyrA inhibitors against urinary tract infection-causing fluoroquinolone resistant Escherichia coli
Authors
Keywords
-
Journal
RSC Advances
Volume 8, Issue 42, Pages 23629-23647
Publisher
Royal Society of Chemistry (RSC)
Online
2018-06-29
DOI
10.1039/c8ra01854e
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of VEGFR2 inhibitors by integrating naïve Bayesian classification, molecular docking and drug screening approaches
- (2018) De Kang et al. RSC Advances
- Immunity to uropathogens: the emerging roles of inflammasomes
- (2017) Claire Hamilton et al. Nature Reviews Urology
- 3-D structural interactions and quantitative structural toxicity studies of tyrosine derivatives intended for safe potent inflammation treatment
- (2016) Ayarivan Puratchikody et al. Chemistry Central Journal
- Suppression of gyrase-mediated resistance by C7 aryl fluoroquinolones
- (2016) Muhammad Malik et al. NUCLEIC ACIDS RESEARCH
- Toward antituberculosis drugs: in silico screening of synthetic compounds against Mycobacterium tuberculosis L,D-transpeptidase 2
- (2016) Junie Billones et al. Drug Design Development and Therapy
- Characterization of Vibrio fluvialis qnrVC5 Gene in Native and Heterologous Hosts: Synergy of qnrVC5 with other Determinants in Conferring Quinolone Resistance
- (2016) Kittappa Vinothkumar et al. Frontiers in Microbiology
- Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases
- (2015) Teresa Kaserer et al. MOLECULES
- Deoxynybomycins inhibit mutant DNA gyrase and rescue mice infected with fluoroquinolone-resistant bacteria
- (2015) Elizabeth I. Parkinson et al. Nature Communications
- Tubulin inhibitors: pharmacophore modeling, virtual screening and molecular docking
- (2014) Miao-miao Niu et al. ACTA PHARMACOLOGICA SINICA
- QSAR and Docking Studies on Capsazepine Derivatives for Immunomodulatory and Anti-Inflammatory Activity
- (2014) Aparna Shukla et al. PLoS One
- Determinants of quinolone resistance in Escherichia coli causing community-acquired urinary tract infection in Bejaia, Algeria
- (2014) Yanat Betitra et al. Asian Pacific Journal of Tropical Medicine
- Effect of N-1/C-8 Ring Fusion and C-7 Ring Structure on Fluoroquinolone Lethality
- (2010) M. Malik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Medicinal Chemist’s Guide to Molecular Interactions
- (2010) Caterina Bissantz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Risk factors and mechanisms of fluoroquinolone resistance in 156 Escherichia coli strains clinically isolated from urinary tract infections
- (2010) Tomihiko Yasufuku et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Comparative Study of the Mutant Prevention Concentrations of Moxifloxacin, Levofloxacin, and Gemifloxacin against Pneumococci
- (2009) K. Credito et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Relationships among Ciprofloxacin, Gatifloxacin, Levofloxacin, and Norfloxacin MICs for Fluoroquinolone-Resistant Escherichia coli Clinical Isolates
- (2008) L. Becnel Boyd et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now